Fix Pharma Forecasts: Common Misinterpretations of the FDA Orange Book That Distort Market Forecasts
In the high-stakes world of pharmaceutical forecasting, precision isn’t just preferred—it’s imperative. Yet, a troubling pattern persists: many market forecasts are built on a shaky foundation, often distorted by misinterpretations of the FDA’s Orange …
